Michael Gelband’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-816,068
| Closed | -$22.9M | – | 1948 |
|
|
2026
Q1 | $22.9M | Sell |
816,068
-666,483
| -45% | -$17.7M | 0.18% | 79 |
|
|
2025
Q4 | $36.9M | Buy |
1,482,551
+993,496
| +203% | +$25.1M | 0.29% | 42 |
|
|
2025
Q3 | $12.5M | Buy |
+489,055
| New | +$12.1M | 0.13% | 152 |
|
|
2025
Q2 | – | Sell |
-1,879,326
| Closed | -$47.6M | – | 1869 |
|
|
2025
Q1 | $47.6M | Buy |
+1,879,326
| New | +$49.2M | 0.47% | 27 |
|
|
2024
Q4 | – | Sell |
-8,884
| Closed | -$241K | – | 1927 |
|
|
2024
Q3 | $257K | Sell |
8,884
-467,113
| -98% | -$13.6M | ﹤0.01% | 1402 |
|
|
2024
Q2 | $13.3M | Buy |
+475,997
| New | +$13.1M | 0.09% | 202 |
|
|
2023
Q4 | – | Sell |
-1,261,820
| Closed | -$41.9M | – | 1916 |
|
|
2023
Q3 | $41.9M | Buy |
1,261,820
+1,245,437
| +7,602% | +$44M | 0.4% | 41 |
|
|
2023
Q2 | $601K | Sell |
16,383
-142,691
| -90% | -$5.55M | ﹤0.01% | 1291 |
|
|
2023
Q1 | $6.49M | Buy |
159,074
+83,397
| +110% | +$3.6M | 0.05% | 422 |
|
|
2022
Q4 | $3.88M | Sell |
75,677
-93,899
| -55% | -$4.5M | 0.06% | 418 |
|
|
2022
Q3 | $7.42M | Buy |
+169,576
| New | +$8.24M | 0.1% | 283 |
|
|
2022
Q2 | – | Sell |
-102,096
| Closed | -$5.29M | – | 2328 |
|
|
2022
Q1 | $5.29M | Sell |
102,096
-216,532
| -68% | -$11.2M | 0.07% | 373 |
|
|
2021
Q4 | $18.8M | Buy |
318,628
+25,556
| +9% | +$1.27M | 0.19% | 83 |
|
|
2021
Q3 | $12.6M | Buy |
+293,072
| New | +$13M | 0.17% | 143 |
|
|
2021
Q1 | – | Sell |
-222,039
| Closed | -$8.17M | – | 2485 |
|
|
2020
Q4 | $8.17M | Buy |
222,039
+182,168
| +457% | +$6.68M | 0.08% | 154 |
|
|
2020
Q3 | $1.39M | Sell |
39,871
-136,192
| -77% | -$4.77M | 0.03% | 545 |
|
|
2020
Q2 | $5.46M | Buy |
176,063
+143,481
| +440% | +$4.87M | 0.14% | 144 |
|
|
2020
Q1 | $1.01M | Sell |
32,582
-33,968
| -51% | -$1.16M | 0.06% | 306 |
|
|
2019
Q4 | $2.47M | Buy |
+66,550
| New | +$2.37M | 0.05% | 290 |
|
|
2019
Q3 | – | Sell |
-6,429
| Closed | -$264K | – | 1563 |
|
|
2019
Q2 | $264K | Sell |
6,429
-223,299
| -97% | -$8.87M | 0.01% | 763 |
|
|
2019
Q1 | $9.26M | Buy |
+229,728
| New | +$9.2M | 0.69% | 22 |
|
Other funds holding PFE
Michael Gelband's PFE Position: Q2 2026 in Review
Michael Gelband sold out of Pfizer (PFE) in Q2 2026, closing a stake of 816,068 shares — an estimated $22.9M sold.
Michael Gelband first reported a position in PFE in Q1 2019 and held it in 21 quarters. The position peaked at $47.6M in Q1 2025. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Michael Gelband reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Michael Gelband sold 816,068 Pfizer shares in Q2 2026, an estimated $22.9M.
- Michael Gelband first reported a position in Pfizer in Q1 2019 and held it in 21 quarters.
- Michael Gelband's Pfizer position peaked at $47.6M in Q1 2025.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.